COMPANY

Caldera Therapeutics

Keywords: antibody bispecific antibody inflammatory bowel disease

Location: Cambridge, MA · source · Jan 21, 2026

Profile checked Oct 10, 2026

Raises and investors new

Form D raises come from the company’s own SEC filing (last 2 years).

InvestorListed in the portfolio of Atlas Venture (captured Oct 12, 2026). portfolio page ↗

SEC Form D raise Raised $37.5M (Form D filed Jan 21, 2026). SEC Form D 0002069936-26-000001 (Jan 21, 2026)
Evidence (1 event)
- Jan 21, 2026 · SEC Form D 0002069936-26-000001
  Name of Issuer: Caldera Therapeutics, Inc.; CIK: 2069936; Address: Cambridge, MA; Submission type: D; Filing date: 2026-01-21; Industry Group: Biotechnology; Date of First Sale: 2026-01-08; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 37500000; Total Amount Sold: 37500000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals